A tailored course, built for your situation
Production-Grade AI in Pharmaceutical R&D Operations for Regulated Industries
Master compliant, scalable AI systems for drug development and clinical innovation
The situation this course is for
Teams invest in AI prototypes only to find they can't meet documentation, traceability, or change control standards required in regulated R&D. This leads to shelved projects, wasted resources, and lost momentum despite strong initial promise.
Who this is for
Technical leaders, R&D operations managers, data governance officers, and compliance architects in pharmaceutical and biotech organizations implementing AI in drug discovery, clinical trials, or manufacturing
Who this is not for
Entry-level data scientists without regulatory exposure, or professionals outside life sciences or regulated product development
What you walk away with
- Architect AI workflows compliant with GxP, 21 CFR Part 11, and data integrity standards
- Implement model validation processes that pass internal and external audits
- Build traceable data pipelines with versioned lineage from raw input to final decision
- Govern AI deployments through change control, SOP integration, and role-based access
- Lead cross-functional initiatives that align data science, QA, and regulatory affairs
The 12 modules (with all 144 chapters)
- Defining production-grade vs. experimental AI
- Regulatory frameworks: GxP, FDA, EMA, ICH guidelines
- AI risk classification in drug development
- Compliance-by-design philosophy
- Roles and responsibilities in regulated AI teams
- Documentation standards for AI artifacts
- Audit readiness fundamentals
- Data privacy in clinical and R&D contexts
- Change management in AI systems
- Validation scope and planning
- Regulatory intelligence sourcing
- Case study: AI in preclinical discovery
- ALCOA+ principles applied to AI data
- Data provenance and chain of custody
- Data qualification vs. validation
- Metadata management for auditability
- Data access controls and audit trails
- Handling PII and sensitive clinical data
- Data versioning strategies
- Raw data retention policies
- Electronic record compliance
- Data reconciliation workflows
- Data integrity risk assessment
- Case study: AI in clinical trial enrollment
- Phased approach to model development
- Protocol-driven model design
- Model specification documentation
- Development environment controls
- Version control for models and code
- Reproducibility of training pipelines
- Use case alignment with regulatory endpoints
- Model performance thresholds
- Development SOP integration
- Peer review and sign-off gates
- Change tracking in model iterations
- Case study: Predictive toxicology modeling
- Validation vs. verification: key distinctions
- Test plan development for AI models
- Performance benchmarking under GxP
- Statistical process controls for AI
- Sensitivity and robustness testing
- Cross-validation in regulated contexts
- Validation report structure
- Independent review requirements
- Ongoing model monitoring validation
- Retraining validation protocols
- Handling model drift documentation
- Case study: AI in manufacturing process control
- Defining AI system configuration items
- Change control board roles and processes
- Impact assessment for model updates
- Deviation management for AI outputs
- Backout and rollback planning
- Versioned deployment pipelines
- Environment segregation (dev/test/prod)
- Release notes and audit documentation
- Post-deployment verification
- Emergency change protocols
- Change freeze periods
- Case study: Updating AI in pharmacovigilance
- Real-time model performance dashboards
- Drift detection and response thresholds
- Automated alerting for data anomalies
- Human-in-the-loop escalation paths
- Audit log review procedures
- Model retraining triggers
- Performance degradation documentation
- Incident reporting workflows
- Key performance indicator tracking
- User feedback integration
- System uptime and availability SLAs
- Case study: Monitoring AI in clinical trial analytics
- Required documentation artifacts
- Metadata capture for audit trails
- Electronic signature compliance
- Document control systems integration
- Versioning and approval workflows
- Audit readiness checklists
- Internal audit preparation
- Regulatory inspection response
- Data retention and archiving
- Document retrieval efficiency
- Cross-referencing validation evidence
- Case study: Preparing for FDA AI audit
- Governance committee structure
- RACI matrices for AI projects
- Stakeholder communication plans
- Regulatory intelligence sharing
- Risk-based decision frameworks
- Budget and resource alignment
- Training and competency tracking
- Vendor oversight for third-party AI
- Knowledge transfer protocols
- Escalation pathways for compliance issues
- Periodic review cycles
- Case study: AI governance in global pharma
- Patient recruitment optimization
- Protocol deviation prediction
- Site performance analytics
- Adverse event pattern detection
- eConsent and digital health tools
- Randomization system integrity
- Monitoring visit prioritization
- Data query automation
- Clinical supply forecasting
- Trial closure analytics
- Patient retention modeling
- Case study: AI in decentralized trials
- Target validation using AI
- Compound screening automation
- ADMET prediction models
- Generative chemistry compliance
- Patent landscape analysis
- Toxicity risk modeling
- Lead optimization workflows
- Biomarker discovery pipelines
- Collaborative AI in CRO partnerships
- Data sharing agreements
- IP protection in AI models
- Case study: AI in oncology target discovery
- Real-time release testing
- Predictive maintenance for equipment
- Batch record review automation
- Raw material quality prediction
- Process analytical technology (PAT)
- Anomaly detection in production
- Quality event root cause analysis
- Deviation trend forecasting
- OOS investigation support
- Supply chain risk modeling
- Sustainability optimization
- Case study: AI in sterile fill-finish
- AI maturity assessment
- Portfolio prioritization frameworks
- Center of excellence models
- Talent acquisition and development
- Budgeting for AI at scale
- Technology stack standardization
- Vendor ecosystem management
- Regulatory strategy alignment
- Global harmonization of AI practices
- Ethics board integration
- Long-term AI governance
- Case study: Enterprise AI transformation
How this maps to your situation
- Transitioning from pilot AI to production deployment
- Preparing for regulatory audit of AI systems
- Scaling AI across multiple R&D functions
- Integrating AI into existing quality management systems
Before vs. after
What's included with your purchase
- 12 modules with 12 chapters each (144 chapters)
- Downloadable templates and worked examples for every module
- Hand-built implementation playbook delivered alongside course access
- 30-day money-back guarantee
Delivery and format
- Course and learning environment access provisioned within 24 hours of purchase
- Hand-built implementation playbook delivered alongside course access
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.
Time investment: Approximately 45, 60 hours of self-paced learning, designed for working professionals.
How this compares to the alternatives
Unlike generic AI courses, this program is built specifically for regulated pharma environments, combining technical depth with compliance rigor and real-world implementation strategies.
Frequently asked
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.